NEUROCRINE BIOSCIENCES INC (NBIX) /
The debt of NEUROCRINE BIOSCIENCES INC over the past 10 years
Chart NEUROCRINE BIOSCIENCES INC: liquid cash, total debt, net cash, fiscal 2016–2025 Open the chart →At the end of fiscal 2025, the latest fiscal year on file, NEUROCRINE BIOSCIENCES INC had liquid cash of $1.48B and total debt of $0: net cash of $1.48B. It had more liquid cash than debt at all 10 year-ends shown. Total debt was highest at the end of fiscal 2019 ($408.8M) and lowest at the end of fiscal 2016 ($0).
Year by year
| Fiscal year | Liquid cash | Total debt* | Net cash* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $1.48B* | $0 | $1.48B |
| 2024ended Dec 31, 2024 | $1.08B* | $0 | $1.08B |
| 2023ended Dec 31, 2023 | $1.03B* | $170.1M | $861.5M |
| 2022ended Dec 31, 2022 | $989.3M* | $169.4M | $819.9M |
| 2021ended Dec 31, 2021 | $711.3M* | $335.1M | $376.2M |
| 2020ended Dec 31, 2020 | $801M* | $317.9M | $483.1M |
| 2019ended Dec 31, 2019 | $670.5M* | $408.8M | $261.7M |
| 2018ended Dec 31, 2018 | $650.91M* | $388.5M | $262.42M |
| 2017ended Dec 31, 2017 | $515.93M* | $369.62M | $146.31M |
| 2016ended Dec 31, 2016 | $307.35M* | $0 | $307.35M |
Fiscal years as NEUROCRINE BIOSCIENCES INC reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on NEUROCRINE BIOSCIENCES INC
- The revenue of NEUROCRINE BIOSCIENCES INC
- The profitability of NEUROCRINE BIOSCIENCES INC
- The cash flow of NEUROCRINE BIOSCIENCES INC
- All of NEUROCRINE BIOSCIENCES INC's financials, charted
Companies of a similar size
- JAZZJazz Pharmaceuticals plc
- PFGCPerformance Food Group Company
- RBCRBC BEARINGS INCORPORATED
- WWayfair Inc.
- SWKSTANLEY BLACK & DECKER, INC.
Not investment advice. This page shows what NEUROCRINE BIOSCIENCES INC filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.